A study by Graupera et al. (2017) revealed that L-FABP has the potential to be applied as a biomarker for detecting liver injury caused by cirrhosis, as L-FABP levels were observed to be greater in individuals with cirrhosis compared to healthy subjects [25]. Here, FABP1 is linked to Cirrhosis.